


Searching News Database: QS-21
HSMN NewsFeed - 13 Jan 2014
Agenus Enters into Definitive Agreement to Acquire Privately Held 4-Antibody AG
Agenus Enters into Definitive Agreement to Acquire Privately Held 4-Antibody AG
HSMN NewsFeed - 5 Sep 2013
GSK’s MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Melanoma Misses First Co-Primary Endpoint
GSK’s MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Melanoma Misses First Co-Primary Endpoint
HSMN NewsFeed - 8 Apr 2008
Oncophage(R) Approved in Russia for the Treatment of Intermediate-Risk Kidney Cancer
Oncophage(R) Approved in Russia for the Treatment of Intermediate-Risk Kidney Cancer
Additional items found! 5
Members Archive contains
5 additional stories matching:
QS-21
(Password required)
QS-21
(Password required)
